US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

37.40

-0.2000-0.53%

Post-market: 37.34-0.0600-0.16%19:30 EDT

Volume:1.60M

Turnover:59.67M

Market Cap:5.03B

PE:-10.74

High:38.14

Open:37.70

Low:36.86

Close:37.60

52wk High:49.70

52wk Low:10.46

Shares:134.37M

Float Shares:129.97M

Volume Ratio:0.66

T/O Rate:1.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.4823

EPS(LYR):-2.0600

ROE:-64.09%

ROA:-20.64%

PB:5.47

PE(LYR):-18.16

Loading ...

Overview Company News Filings

Definium Therapeutics issues inducement stock options for 155,480 shares to new hires

Definium Therapeutics Shareholders Approve All Annual Meeting Proposals

Definium Therapeutics shareholders approve 5 million-share increase to equity incentive plan

Definium Therapeutics issues inducement stock options for 462,190 shares to new hires

Definium Therapeutics to join Jefferies Global Healthcare Conference fireside chat

Definium Therapeutics Nears Pivotal Earnings Call Tests

LifeSci Capital Remains a Buy on Definium Therapeutics (DFTX)

Stock Track | Definium Therapeutics Soars 5.15% Intraday After Analyst Reiterates Buy Rating with $70 Price Target on Pipeline Confidence

Definium Therapeutics: Buy Rating Reiterated with Unchanged $70 Price Target on Robust Late-Stage DT120 Pipeline and De-Risked Phase 3 Programs

Definium Therapeutics says first patient dosed in Ascend study

BRIEF-Definium Therapeutics Announces First Patient Dosed In Ascend

Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 Odt in Major Depressive Disorder

THOMSON REUTERS

Definium Therapeutics Inc: Topline Data From 12-Week Double-Blind Period Is Anticipated in 2027

THOMSON REUTERS

Definium Therapeutics grants inducement stock options for 255,340 shares to new hires

Definium Therapeutics Is Maintained at Overweight by Piper Sandler

Stock Track | Definium Therapeutics Plummets 5.34% Intraday Following Analyst Price Target Reduction

RBC Capital Reaffirms Their Buy Rating on Definium Therapeutics (DFTX)

Definium Therapeutics price target lowered to $48 from $49 at Piper Sandler

Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Argenx Se (ARGX) and Definium Therapeutics (DFTX)

Definium Therapeutics releases corporate presentation outlining DT120 ODT Phase 3 program in GAD, MDD

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/DFTX/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":37.4,"timestamp":1790971200000,"preClose":37.6,"halted":0,"volume":1598751,"hourTrading":{"tag":"盘后","latestPrice":37.34,"preClose":37.4,"latestTime":"19:30 EDT","volume":61050,"amount":2281098.8977,"timestamp":1790983803977,"change":-0.06,"changeRate":-0.001604,"amplitude":0.014706},"delay":0,"changeRate":-0.005319148936170288,"floatShares":129971489,"shares":134366950,"eps":-3.482311,"marketStatus":"Market Closed","change":-0.2,"latestTime":"10-02 16:00:00 EDT","open":37.7,"high":38.14,"low":36.86,"amount":59672162.826738,"amplitude":0.034043,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":37.6,"preHourTrading":{"tag":"盘前","latestPrice":37.67,"preClose":37.6,"latestTime":"09:29 EDT","volume":2200,"amount":83076.114,"timestamp":1790947799999,"change":0.07,"changeRate":0.001862,"amplitude":0.019415},"postHourTrading":{"tag":"盘后","latestPrice":37.34,"preClose":37.4,"latestTime":"19:30 EDT","volume":61050,"amount":2281098.8977,"timestamp":1790983803977,"change":-0.06,"changeRate":-0.001604,"amplitude":0.014706},"volumeRatio":0.6580987443165245,"impliedVol":0.6021,"impliedVolPercentile":0.0056},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":129971489,"roa":"-20.64%","roe":"-64.09%","lyrEps":-2.059999,"volumeRatio":0.6580987443165245,"shares":134366950,"dividePrice":0,"high":38.14,"amplitude":0.034043,"preClose":37.6,"low":36.86,"week52Low":10.4646,"pbRate":"5.47","week52High":49.7,"institutionHeld":0,"latestPrice":37.4,"eps":-3.482311,"divideRate":0,"volume":1598751,"delay":0,"ttmEps":-3.482311,"open":37.7,"prevYearClose":13.39,"prevWeekClose":36.17,"prevMonthClose":38.06,"prevQuarterClose":38.06,"fiveDayClose":36.17,"twentyDayClose":38,"sixtyDayClose":48.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"DFTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-1.44},{"market":"US","date":"2026-05-07","symbol":"DFTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.71},{"market":"US","date":"2026-02-26","symbol":"DFTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.6111,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6111,"analysts":18,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-10-02","current":-10.739994,"percent":0.376404,"low":-27.074722,"twenty":-17.093203,"median":-11.537867,"eighty":-9.941944,"high":-8.802064,"avg":-13.982706,"sd":5.175129,"marketCap":5052197320},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-06","current":-9.522872,"twenty":-10.196799,"median":-9.918438,"eighty":-9.522872,"marketCap":1600775783},{"date":"2026-02-13","current":-9.511152,"twenty":-10.179218,"median":-9.944809,"eighty":-9.522872,"marketCap":1598805598},{"date":"2026-02-20","current":-10.120616,"twenty":-10.18039,"median":-9.944809,"eighty":-9.520528,"marketCap":1701255248},{"date":"2026-02-27","current":-9.267085,"twenty":-10.187422,"median":-9.96239,"eighty":-9.520528,"marketCap":1703225433},{"date":"2026-03-06","current":-9.519961,"twenty":-10.18039,"median":-9.903787,"eighty":-9.502065,"marketCap":1749702163},{"date":"2026-03-13","current":-9.753213,"twenty":-10.18039,"median":-9.918437,"eighty":-9.518199,"marketCap":1792572359},{"date":"2026-03-20","current":-10.122078,"twenty":-10.169841,"median":-9.903787,"eighty":-9.52229,"marketCap":1860367087},{"date":"2026-03-27","current":-10.273963,"twenty":-10.169841,"median":-9.918437,"eighty":-9.559599,"marketCap":1888282563},{"date":"2026-04-02","current":-11.174427,"twenty":-10.181562,"median":-9.918437,"eighty":-9.550417,"marketCap":2053781457},{"date":"2026-04-10","current":-11.619234,"twenty":-10.247114,"median":-9.944809,"eighty":-9.57529,"marketCap":2135533923},{"date":"2026-04-17","current":-12.18338,"twenty":-10.396104,"median":-9.980506,"eighty":-9.589394,"marketCap":2239219977},{"date":"2026-04-24","current":-12.617338,"twenty":-11.167918,"median":-10.038572,"eighty":-9.618687,"marketCap":2318978480},{"date":"2026-05-01","current":-11.86876,"twenty":-11.389236,"median":-10.10442,"eighty":-9.643639,"marketCap":2181395062},{"date":"2026-05-08","current":-13.767387,"twenty":-11.71579,"median":-10.122078,"eighty":-9.665202,"marketCap":2530349365},{"date":"2026-05-15","current":-9.802755,"twenty":-11.643102,"median":-10.113211,"eighty":-9.689477,"marketCap":2328575817},{"date":"2026-05-22","current":-10.399644,"twenty":-11.570414,"median":-10.105791,"eighty":-9.636028,"marketCap":2470362634},{"date":"2026-05-29","current":-10.780735,"twenty":-11.483622,"median":-10.120616,"eighty":-9.642537,"marketCap":2560888064},{"date":"2026-06-05","current":-11.290386,"twenty":-11.393576,"median":-10.145827,"eighty":-9.660184,"marketCap":2681952193},{"date":"2026-06-12","current":-11.069996,"twenty":-11.344489,"median":-10.179218,"eighty":-9.68473,"marketCap":2629600138},{"date":"2026-06-18","current":-11.216923,"twenty":-11.349156,"median":-10.196799,"eighty":-9.702279,"marketCap":2664501508},{"date":"2026-06-26","current":-20.565124,"twenty":-11.510745,"median":-10.247973,"eighty":-9.723056,"marketCap":4885101210},{"date":"2026-07-02","current":-24.252692,"twenty":-11.77112,"median":-10.299843,"eighty":-9.753213,"marketCap":5761057223},{"date":"2026-07-10","current":-27.074722,"twenty":-12.069466,"median":-10.333633,"eighty":-9.796609,"marketCap":6431410656},{"date":"2026-07-17","current":-24.643864,"twenty":-12.519698,"median":-10.492938,"eighty":-9.802755,"marketCap":5853977501},{"date":"2026-07-24","current":-23.990048,"twenty":-12.931958,"median":-10.537388,"eighty":-9.812883,"marketCap":5698667894},{"date":"2026-07-31","current":-24.861803,"twenty":-14.440728,"median":-10.67054,"eighty":-9.817222,"marketCap":5905747370},{"date":"2026-08-07","current":-17.312135,"twenty":-19.588062,"median":-10.789918,"eighty":-9.824231,"marketCap":6124773739},{"date":"2026-08-14","current":-16.673146,"twenty":-17.887875,"median":-10.831241,"eighty":-9.831914,"marketCap":5898709105},{"date":"2026-08-21","current":-17.242844,"twenty":-17.526933,"median":-11.058518,"eighty":-9.861594,"marketCap":6100259530},{"date":"2026-08-28","current":-16.642763,"twenty":-17.426666,"median":-11.092954,"eighty":-9.887379,"marketCap":5887959749},{"date":"2026-09-04","current":-14.432336,"twenty":-17.33018,"median":-11.139168,"eighty":-9.901443,"marketCap":5105944100},{"date":"2026-09-11","current":-14.329791,"twenty":-17.27056,"median":-11.195675,"eighty":-9.903787,"marketCap":5069665023},{"date":"2026-09-18","current":-14.690599,"twenty":-17.210941,"median":-11.23988,"eighty":-9.921368,"marketCap":5197313626},{"date":"2026-09-25","current":-13.949992,"twenty":-17.164605,"median":-11.372203,"eighty":-9.935823,"marketCap":4935298073},{"date":"2026-10-02","current":-14.280417,"twenty":-17.093203,"median":-11.537867,"eighty":-9.941944,"marketCap":5052197320}],"updateTime":1791060133178},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643785383","title":"Definium Therapeutics issues inducement stock options for 155,480 shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2643785383","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643785383?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:01","pubTimestamp":1781553672,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issued inducement stock options covering 155,480 common shares to six newly hired non-executive employees.Options carry an exercise price set at the closing share price on June 15, 2026.Vesting spans four years: 25% after one year, remaining 75% in substantially equal monthly installments over the next three years.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL9m0ZGF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643740215","title":"Definium Therapeutics Shareholders Approve All Annual Meeting Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2643740215","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643740215?lang=en_us&edition=fundamental","pubTime":"2026-06-13 07:05","pubTimestamp":1781305522,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has issued an announcement. On June 11, 2026, Definium Therapeutics, Inc. held its Annual Meeting, where a quorum...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-shareholders-approve-all-annual-meeting-proposals?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-shareholders-approve-all-annual-meeting-proposals?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643940218","title":"Definium Therapeutics shareholders approve 5 million-share increase to equity incentive plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2643940218","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643940218?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:31","pubTimestamp":1781296272,"startTime":"0","endTime":"0","summary":"Definium Therapeutics held its annual general and special meeting of shareholders on June 11, 2026.Shareholders passed an amendment to the 2025 Equity Incentive Plan, lifting the share reserve by 5 million common shares; the amendment took effect on approval.KPMG LLP was reappointed as independent registered public accounting firm through the 2027 annual meeting.Shareholders also voted in favor of the company’s slate of seven board nominees to serve until the 2027 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Comm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL7ZF4y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640884964","title":"Definium Therapeutics issues inducement stock options for 462,190 shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2640884964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640884964?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:01","pubTimestamp":1780344086,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issued inducement stock options covering 462,190 common shares to 13 newly hired non-executive employees.Grants carry effective dates of May 18, 2026, and June 1, 2026; exercise price set at the closing share price on each grant date.Award schedule calls for 25% vesting on the first anniversary, with the remaining 75% vesting in roughly equal monthly installments over three years.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLbQnqPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637738033","title":"Definium Therapeutics to join Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2637738033","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637738033?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:01","pubTimestamp":1779361278,"startTime":"0","endTime":"0","summary":"Definium Therapeutics management to join a fireside chat at the Jefferies Global Healthcare Conference in New York on June 3, 2026 at 3:10 p.m. EDT.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 21, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL4d9jmd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636813319","title":"Definium Therapeutics Nears Pivotal Earnings Call Tests","url":"https://stock-news.laohu8.com/highlight/detail?id=2636813319","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636813319?lang=en_us&edition=fundamental","pubTime":"2026-05-20 13:49","pubTimestamp":1779256195,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc. (($DFTX)) has held its Q1 earnings call. Read on for the main highlights of the call. Definium Therapeutics’ latest ear...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-nears-pivotal-earnings-call-tests?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-nears-pivotal-earnings-call-tests?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635665210","title":"LifeSci Capital Remains a Buy on Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635665210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635665210?lang=en_us&edition=fundamental","pubTime":"2026-05-16 22:35","pubTimestamp":1778942151,"startTime":"0","endTime":"0","summary":"In a report released today, Francois Brisebois from LifeSci Capital maintained a Buy rating on Definium Therapeutics, with a price target of $38.00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138713954","title":"Stock Track | Definium Therapeutics Soars 5.15% Intraday After Analyst Reiterates Buy Rating with $70 Price Target on Pipeline Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1138713954","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138713954?lang=en_us&edition=fundamental","pubTime":"2026-05-14 01:45","pubTimestamp":1778694302,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) stock soared 5.15% during intraday trading on Wednesday, marking a significant upward movement.The surge follows a positive analyst note from H.C. Wainwright, where...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635090783","title":"Definium Therapeutics: Buy Rating Reiterated with Unchanged $70 Price Target on Robust Late-Stage DT120 Pipeline and De-Risked Phase 3 Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2635090783","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635090783?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:35","pubTimestamp":1778668536,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on DFTX stock, giving a Buy rating today. Patrick Trucchio has given h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/definium-therapeutics-buy-rating-reiterated-with-unchanged-70-price-target-on-robust-late-stage-dt120-pipeline-and-de-risked-phase-3-programs-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/definium-therapeutics-buy-rating-reiterated-with-unchanged-70-price-target-on-robust-late-stage-dt120-pipeline-and-de-risked-phase-3-programs-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634111902","title":"Definium Therapeutics says first patient dosed in Ascend study","url":"https://stock-news.laohu8.com/highlight/detail?id=2634111902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634111902?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:39","pubTimestamp":1778589593,"startTime":"0","endTime":"0","summary":"Definium Therapeutics (DFTX) announced that the first patient has been dosed in Ascend, its second Phase 3 study evaluating DT120 ODT for the treat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-says-first-patient-dosed-in-ascend-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-says-first-patient-dosed-in-ascend-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634145218","title":"BRIEF-Definium Therapeutics Announces First Patient Dosed In Ascend","url":"https://stock-news.laohu8.com/highlight/detail?id=2634145218","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634145218?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583658,"startTime":"0","endTime":"0","summary":"BRIEF-Definium Therapeutics Announces First Patient Dosed In AscendMay 12 (Reuters) - Definium Therapeutics Inc DFTX.O:DEFINIUM THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN ASCEND, THE SECOND PHASE 3","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA1J1TPL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634221890","title":"Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 Odt in Major Depressive Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2634221890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634221890?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583604,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA1J1TPL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634218985","title":"Definium Therapeutics Inc: Topline Data From 12-Week Double-Blind Period Is Anticipated in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2634218985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634218985?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:00","pubTimestamp":1778583604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA1J1TPL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634510232","title":"Definium Therapeutics grants inducement stock options for 255,340 shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2634510232","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634510232?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:01","pubTimestamp":1778529679,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issued inducement stock options covering 255,340 common shares to five newly hired non-executive employees, with grant dates of April 27, May 4, May 11, 2026.Exercise price set at closing share price on each grant date.Vesting scheduled over four years, with 25% vesting on first anniversary of grant date, then remaining 75% vesting in substantially equal monthly installments over next three years, subject to continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on May 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL8P0Dbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633450206","title":"Definium Therapeutics Is Maintained at Overweight by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2633450206","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633450206?lang=en_us&edition=fundamental","pubTime":"2026-05-08 23:15","pubTimestamp":1778253300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 08, 2026 11:15 ET (15:15 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105677630","title":"Stock Track | Definium Therapeutics Plummets 5.34% Intraday Following Analyst Price Target Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=1105677630","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105677630?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:35","pubTimestamp":1778247358,"startTime":"0","endTime":"0","summary":"Definium Therapeutics' stock plummeted 5.34% during intraday trading on Friday.The decline follows Piper Sandler analyst David Amsellem lowering the firm's price target on Definium Therapeutics to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633595534","title":"RBC Capital Reaffirms Their Buy Rating on Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633595534","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633595534?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:41","pubTimestamp":1778244066,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Definium Therapeutics, with a price target of $36.00. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-buy-rating-on-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633257458","title":"Definium Therapeutics price target lowered to $48 from $49 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2633257458","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633257458?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:19","pubTimestamp":1778239157,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst David Amsellem lowered the firm’s price target on Definium Therapeutics (DFTX) to $48 from $49 and keeps an Overweight rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-lowered-to-48-from-49-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-price-target-lowered-to-48-from-49-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633175436","title":"Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Argenx Se (ARGX) and Definium Therapeutics (DFTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633175436","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633175436?lang=en_us&edition=fundamental","pubTime":"2026-05-08 16:51","pubTimestamp":1778230270,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alcon (ALC), Argenx Se (ARGX) and Definium Therapeutics (DFTX). A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alcon-alc-argenx-se-argx-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alcon-alc-argenx-se-argx-and-definium-therapeutics-dftx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","IE0002141913.USD","LU2324357040.USD","BK4505","LU0320765992.SGD","XLV","BK4585","BK4581","BK4588","LU0029874061.USD","ALC","IE00B2B36J28.USD","XBI","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4534","BK4137","LU0109394709.USD","LABU","LU0128526141.USD","LU0889565916.HKD","BK4007","BK4139","IE00BFTCPJ56.SGD","IE0034235188.USD","DFTX","LU1804176565.USD","ARGX","IE00B4R5TH58.HKD","LU1983260115.SGD","IE00BJT1NW94.SGD","LU2265009873.SGD","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633105303","title":"Definium Therapeutics releases corporate presentation outlining DT120 ODT Phase 3 program in GAD, MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2633105303","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633105303?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:46","pubTimestamp":1778193961,"startTime":"0","endTime":"0","summary":"Definium outlined late-stage plans for DT120 ODT, its lead program, with five Phase 3 studies across generalized anxiety disorder and major depressive disorder.Three Phase 3 readouts are anticipated in 2026, framed as key catalysts for potential commercial opportunities in GAD and MDD.Cash, cash equivalents, and investments totaled USD 373.4 million as of March 31, 2026, with cash runway expected to extend into 2028.Phase 2b data highlighted a single 100 g dose with a 21.9-point HAM-A improvement at Week 12, a 7.7-point placebo-adjusted difference, and 48% remission at Week 12.Pipeline also includes DT402, an R(-)-MDMA program in development for autism spectrum disorder.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLsffrC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}